AlphaQuest LLC Has $483,000 Position in Colgate-Palmolive Company $CL

Key Points

• AlphaQuest LLC has significantly reduced its stake in Colgate-Palmolive by 57.5%, now holding shares worth $483,000 following the sale of 6,965 shares in the first quarter.
• Colgate-Palmolive reported an earnings per share (EPS) of $0.92 for the last quarter, exceeding analysts' estimates, with a revenue of $5.11 billion, representing a 1.0% year-over-year increase.
• The company announced a quarterly dividend of $0.52 per share, yielding approximately 2.5%, with a dividend payout ratio of 58.43%.

AlphaQuest LLC decreased its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 57.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,150 shares of the company's stock after selling 6,965 shares during the period. AlphaQuest LLC's holdings in Colgate-Palmolive were worth $483,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. Personal CFO Solutions LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $285,000. Vision Capital Management Inc. bought a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $322,000. Autumn Glory Partners LLC boosted its position in shares of Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after purchasing an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. bought a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $2,166,000. Finally, Penserra Capital Management LLC boosted its position in shares of Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock valued at $997,000 after purchasing an additional 8,515 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 0.7%

Shares of CL stock traded up $0.62 during trading on Monday, hitting $84.04. 3,934,689 shares of the company were exchanged, compared to its average volume of 4,656,227. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market capitalization of $67.92 billion, a price-to-earnings ratio of 23.61, a P/E/G ratio of 4.37 and a beta of 0.35. The business's 50-day simple moving average is $87.06 and its 200 day simple moving average is $89.84. Colgate-Palmolive Company has a twelve month low of $82.40 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $0.91 earnings per share. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Analysts Set New Price Targets

Several research firms have recently weighed in on CL. Citigroup reduced their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a report on Monday, August 4th. Barclays raised their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Finally, UBS Group decreased their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.